Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets recover lost ground
Wed, 19 Aug 11:30 am

After facing losses in the early hours of the trade, the Indian Markets reversed direction and have rushed into the green. Sectoral indices are trading on a mixed note with stocks from the pharma and software sectors leading the gains.

The BSE-Sensex is trading up 96 points (up 0.4%) and the NSE-Nifty is trading up 32 points (up 0.4%). The S&P BSE Midcap index is trading up by 0.3% while the S&P BSE Smallcap index is trading up by 0.5%. The rupee is trading at 65.26 to the US dollar.

Pharma stocks are trading on strong note with Natco Pharma and Glenmark Pharma leading the gains. As per a leading financial daily, Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (USFDA) for Drospirenone and Ethinyl tablets. These are the generic version of Yaz tablets of Bayer Healthcare Pharmaceuticals Inc. The company is planning to commence its shipping operations of Drospirenone and Ethinyl tablets USP (United States Pharmacopeia), 3 mg/0.02mg. The current portfolio of company consists of 101 products authorized for distribution in the US marketplace and 64 ANDA's (Abbreviated New Drug Application) pending approval with the USFDA. Presently the stock of Glenmark Pharmaceuticals is trading up by 5.4%.

Power stocks are trading mixed with Jaiprakash Power and GVK Power & Infra leading the gains. According to a leading financial daily, Power Grid Corporation has declared the commissioning of Rs 120 bn transmission line between Assam and Agra by this month-end. This will have a total capacity of 6,000 MW. This will integrate the North-Eastern region with other regions of the country to facilitate smooth and reliable power transfer. The same will also lead to socio-economic development of India as a whole and the region in particular. Scrip of Power Grid is currently trading marginally lower.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets recover lost ground". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.